Results 121 to 130 of about 57,995 (263)

Peptide receptor radionuclide therapy [PDF]

open access: yes, 2005
Peptide receptor radionuclide therapy is a new treatment modality for patients with inoperable or metastasised neuroendocrine gastroenteropancreatic tumours.
Esser, J.-P. (Jan-Paul)   +5 more
core   +1 more source

Tumor‐infiltrating immune cells predict the response to somatostatin receptor ligands only in somatotropinomas naïve to medical therapy

open access: yesJournal of Neuroendocrinology, Volume 37, Issue 11, November 2025.
Abstract Tumor‐infiltrating immune cells (TICs) are important components of the tumor microenvironment (TME). They regulate somatotroph adenoma treatment responses to therapy with somatostatin receptor ligands (SRLs), mediated by soluble factors and cytokines. In this study, we assessed the effect of SRLs treatment on TICs.
Sabrina Chiloiro   +16 more
wiley   +1 more source

Somatostatin receptor subtypes in human thymoma and inhibition of cell proliferation by octreotide in vitro [PDF]

open access: yes, 2000
Somatostatin (SS) and SS receptor (SSR) subtypes, code-named sst1-5, are heterogeneously expressed in the normal human thymus. This suggests their involvement in controlling the immune and/or neuroendocrine functions in this organ ...
Colao, A. (Annamaria)   +9 more
core   +1 more source

Clinical Practice Guideline for Headache Disorders 2021

open access: yesNeurology and Clinical Neuroscience, Volume 13, Issue 6, Page 389-407, November 2025.
ABSTRACT The International Headache Society published the International Classification of Headache Disorders, 3rd edition in 2018. In this classification, Chapter 3—previously “Cluster headache and other trigeminal‐autonomic cephalalgias”—was renamed “Trigeminal‐autonomic cephalalgias (TACs).” Trigeminal‐autonomic cephalalgias are a group of disorders ...
Nobuo Araki   +10 more
wiley   +1 more source

Nuclear medicine in endocrine tumours [PDF]

open access: yes, 2011
C
Peremans, Kathelijne   +1 more
core   +2 more sources

Differential Effects of Somatostatin on TNF Receptors and Apoptosis in Hepatocellular Carcinoma Cell Lines

open access: yesGastroenterology Insights
The anti-tumoral activity of somatostatin has been demonstrated in both animal experiments and human tumors. Clinical trials have reported conflicting results.
Maria Georgiadou   +6 more
doaj   +1 more source

Refractory Thrombocytopenia Responds to Octreotide Treatment in a Case of Evans Syndrome with Gastric Neuroendocrine Tumor

open access: yesCase Reports in Hematology, 2013
A 37-year-old woman with history of Evans Syndrome with poor response to high-dose corticoid treatment presented to the emergency department with gastrointestinal and vaginal bleeding.
Kocfa Chung-Delgado   +4 more
doaj   +1 more source

In Vitro Head-to-Head Comparison Between Octreotide and Pasireotide in GH-Secreting Pituitary Adenomas [PDF]

open access: bronze, 2017
Federico Gatto   +10 more
openalex   +1 more source

EVALUATION OF THE SPATIAL RESOLUTION IN MONTE CARLO-BASED SPECT/CT RECONSTRUCTION OF 111IN-OCTREOTIDE IMAGES [PDF]

open access: hybrid, 2021
Emma Wikberg   +5 more
openalex   +1 more source

A Multicenter Evaluation of Octreotide for Ventricular Assist Device Related Gastrointestinal Bleeding [PDF]

open access: bronze, 2016
George Smallfield   +8 more
openalex   +1 more source

Home - About - Disclaimer - Privacy